Baseline Serum HE4 But Not Tissue HE4 Expression Predicts Response to the Levonorgestrel-Releasing Intrauterine System in Atypical Hyperplasia and Early Stage Endometrial Cancer

The levonorgestrel-releasing intrauterine system (LNG-IUS) is a conservative management option for atypical hyperplasia (AH) and low grade early stage endometrial cancer (EEC), but around 1 in 3 patients fail to respond to treatment. The aim of this study was to investigate if serum and/or tissue HE...

Descripción completa

Detalles Bibliográficos
Autores principales: Behrouzi, Roya, Ryan, Neil A. J., Barr, Chloe E., Derbyshire, Abigail E., Wan, Y. Louise, Maskell, Zoe, Stocking, Katie, Pemberton, Philip W., Bolton, James, McVey, Rhona J., Crosbie, Emma J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073190/
https://www.ncbi.nlm.nih.gov/pubmed/31979212
http://dx.doi.org/10.3390/cancers12020276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073190/
https://www.ncbi.nlm.nih.gov/pubmed/31979212
http://dx.doi.org/10.3390/cancers12020276

Ejemplares similares